Written and maintained by CASRAI Editorial Board
Last updated
The Annals of Pharmacotherapy (NLM abbreviation Ann Pharmacother) is a monthly, peer-reviewed pharmacotherapy journal published by Sage. This guide is for authors and readers who need to know what the journal publishes, how it is indexed, which article types it accepts with what limits, and what publishing in it costs. Facts below come from the journal’s Sage author instructions (copy dated 25 June 2025) and the NLM Catalog record (revised 2026-05-08), both checked 2026-11-08.
What it is
The journal’s NLM Catalog title is “The Annals of pharmacotherapy” (NLM ID 9203131). It began under this title in 1992; its preceding title was DICP. ISSNs are 1060-0280 (print) and 1542-6270 (electronic). It appears monthly, with July and August combined, in English.
“Annals of Pharmacology” and other name variants
People also search for “Annals of Pharmacology” or “Annals of Pharmacotherapy journal”. The journal described here is titled The Annals of Pharmacotherapy; use that title or the abbreviation Ann Pharmacother when searching a database or citing it.
Who runs it and how it is indexed
- Publisher: Sage. Submissions go through Sage Track, a ScholarOne-based system.
- Indexing: the NLM Catalog lists the journal as currently indexed in MEDLINE (full) and in PubMed.
- Impact factor: the Sage page shows a journal impact factor of 2.3 and a five-year figure of 2.7 in the 2025 copy. Figures change each year, so read the current value on the journal’s Sage page before quoting it.
- Ethics frameworks: the journal states it is a member of the Committee on Publication Ethics (COPE) and follows the recommendations of the ICMJE.
- Peer review: double anonymized.
- Access and preprints: subscription journal; it accepts submissions that have been posted as a preprint.
Article types and limits
The table lists limits stated in the Sage author instructions. Check the live instructions before submitting, since they are revised.
| Article type | Abstract | References | Other stated limits |
|---|---|---|---|
| Research Report | Under 300 words, structured (Background, Objective, Methods, Results, Conclusion and Relevance) | Up to 30 | IRB statement required; meta-analyses are treated as research; PRISMA encouraged; prospective studies are highest priority |
| Review Article | Under 300 words | Up to 100 | The literature search methods must be described |
| Review Article: New Drug Approval | Under 250 words | Up to 30 | Up to 4 tables/figures; must compare the drug with existing FDA-approved drugs |
| Special Contribution | Under 300 words, unstructured | 15 | 1 table/figure; contact the editorial office (aop at sagepub.com) first |
| Editorial | Under 250 words | 20 | 2 tables/figures; contact the editorial office first |
| Commentary | Under 100 words | 20 | 2 tables/figures; contact the editorial office first |
| Letter to the Editor | None | 10 | Text up to 500 words; 2 tables/figures; maximum five authors; comments on an article should arrive within 6 months of its publication |
Letters reporting an adverse drug reaction are expected to use the Naranjo scale, and letters on drug interactions the DIPS scale, according to the instructions.
Fees and open access
- The instructions state there are no fees to submit or publish.
- Open access is optional, through Sage Choice or open access agreements, and carries a fee.
- Colour in print costs $800 for the first page and $200 for each additional page; colour online is free.
For how access models differ in general, see open access.
Where to find the submission site
Use the submission link on the journal’s Sage page (journals.sagepub.com/author-instructions/AOP). Check whether you already have a Sage Track account before creating one.
Strengths and limits
- Clear fit: the article types are built around drug therapy, including a dedicated new-drug-approval review format that requires comparison with approved drugs.
- Short formats are tightly capped: letters are limited to 500 words and ten references, and commentaries to a 100-word abstract.
- Cost: no publication fee, but colour print pages and open access are charged.
Alternatives
This page does not rank journals. For another journal profile in the same cluster, see the JAAPA journal guide.
FAQ
Is the Annals of Pharmacotherapy indexed in MEDLINE and PubMed?
Yes. The NLM Catalog record (revised 2026-05-08) lists both as current.
What is the journal’s impact factor?
The Sage page copy dated 25 June 2025 shows 2.3 (five-year 2.7). Read the current figure on the journal page.
Does it charge to publish?
No submission or publication fee is stated. Optional open access and print colour pages are charged.
Is peer review blind?
The instructions describe double anonymized review.
Is “Annals of Pharmacology” the same journal?
The journal in the NLM Catalog under this record is titled The Annals of Pharmacotherapy. Cite that title.
Sources
- Sage, Annals of Pharmacotherapy author instructions (copy dated 25 June 2025), checked 2026-11-08.
- NLM Catalog, record 9203131, revised 2026-05-08, checked 2026-11-08.
